Bayer to Sell U.S. And Canadian Livestock And Equine Biologicals Business

  • Print
  • Email
  • Favorite
  • Share
  • Newsletters

The Animal Health business group of Bayer Corporation's Agriculture Division has agreed to sell the group's U.S. and Canadian livestock and equine biologicals business to Intervet Inc. The Bayer unit manufactures biological vaccines for cattle, swine and horses. The deal is expected to close on July 31, 2000, subject to regulatory approval.

"The biologicals unit for Bayer's animal

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners